Australia HPB Surgery Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE AUSTRALIA HPB SURGERY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 DBMR VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 HEALTHCARE EXPENDITURE WITH A FOCUS ON HPB SURGERY

4.3.1 PROCEDURES:

4.3.2 CHOLECYSTECTOMY

4.3.3 COLONOSCOPY

4.4 HEPATO-PANCREATO-BILIARY SURGERY VOLUME TREND

4.5 EPIDEMIOLOGY

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASING NUMBER OF DISEASES ASSOCIATED WITH THE LIVER AND PANCREAS

5.1.2 GROWING TREND OF GALL BLADDER CONCERNS IN YOUNGER ADULTS

5.1.3 TECHNOLOGICAL ADVANCEMENTS IN ELECTROSURGERY INSTRUMENTS

5.1.4 RISE OF MINIMALLY INVASIVE SUSRGERY

5.2 RESTRAINTS

5.2.1 RISING ATTENTION TO HEALTHY DIET

5.2.2 CONCERNS ASSOCIATED WITH POST-SURGERY COMPLICATIONS

5.2.3 INCORPORATION OF AI TECHNOLOGY IN SURGICAL DEVICES

5.2.4 INCREASING COLLABORATIONS AND PARTNERSHIPS

5.2.5 INCREASED NUMBER OF TRAINING AND EDUCATION PROGRAMS

5.3 CHALLENGES

5.3.1 LACK OF PROPER HEALTHCARE FACILITIES IN DEVELOPING REGION

5.3.2 SHORTAGE OF TRAINED PROFESSIONALS

6 AUSTRALIA HPB SURGERY MARKET, BY APPLICATION

6.1 OVERVIEW

6.2 TUMOR RESECTION AND TREATMENT

6.2.1 LIVER TUMORS

6.2.1.1 HEPATOCELLULAR CARCINOMA

6.2.1.2 METASTASIS

6.2.2 PANCREATIC TUMORS

6.2.2.1 PANCREATIC ADENOCARCINOMA

6.2.2.2 NEUROENDOCRINE TUMORS

6.2.3 BILIARY TRACT CANCERS

6.2.3.1 CHOLANGIOCARCINOMA

6.2.3.2 GALLBLADDER CARCINOMA

6.3 LAPAROSCOPIC CHOLECYSTECTOMY

6.4 OTHERS

7 AUSTRALIA HPB SURGERY MARKET, BY TECHNOLOGY

7.1 OVERVIEW

7.2 LAPAROSCOPIC SYSTEMS & ROBOTIC ASSISTED TOOLS

7.3 INTRAOPERATIVE ULTRASOUND SYSTEMS FOR TUMOR LOCALIZATION

7.4 ELECTROSURGICAL AND ENERGY-BASED DEVICES

7.5 ADVANCED IMAGING SYSTEMS

8 AUSTRALIA HPB SURGERY MARKET, BY PROCEDURE TYPE

8.1 OVERVIEW

8.2 LAPAROSCOPIC SURGERY

8.3 OPEN SURGERY

8.4 ROBOTIC-ASSISTED SURGERY

9 AUSTRALIA HPB SURGERY MARKET, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS

9.3 SPECIALITY CANCER HOSPITALS

9.4 AMBULATORY SURGICAL CENTERS(ACS)

9.5 OTHERS

10 AUSTRALIA HPB SURGERY MARKET: COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: AUSTRALIA

11 SWOT ANALYSIS

12 COMPANY PROFILES

12.1 MEDTRONIC

12.1.1 COMPANY SNAPSHOT

12.1.2 REVENUE ANALYSIS

12.1.3 PRODUCT PORTFOLIO

12.1.4 RECENT DEVELOPMENT

12.2 OLYMPUS CORPORATION

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 PRODUCT PORTFOLIO

12.2.4 RECENT DEVELOPMENT

12.3 JOHNSON & JOHNSON SERVICES, INC

12.3.1 COMPANY SNAPSHOT

12.3.2 REVENUE ANALYSIS

12.3.3 PRODUCT PORTFOLIO

12.3.4 RECENT DEVELOPMENTS

12.4 SIEMENS HEALTHINEERS

12.4.1 COMPANY SNAPSHOT

12.4.2 REVENUE ANALYSIS

12.4.3 PRODUCT PORTFOLIO

12.4.4 RECENT DEVELOPMENT

12.5 BOSTON SCIENTIFIC CORPORATION

12.5.1 COMPANY SNAPSHOT

12.5.2 REVENUE ANALYSIS

12.5.3 PRODUCT PORTFOLIO

12.5.4 RECENT DEVELOPMENT

12.6 FUJIFILM HOLDINGS CORPORATION

12.6.1 COMPANY SNAPSHOT

12.6.2 REVENUE ANALYSIS

12.6.3 PRODUCT PORTFOLIO

12.6.4 RECENT DEVELOPMENT

12.7 GE HEALTHCARE

12.7.1 COMPANY SNAPSHOT

12.7.2 REVENUE ANALYSIS

12.7.3 PRODUCT PORTFOLIO

12.7.4 RECENT DEVELOPMENT

12.8 INTUITIVE SURGICAL OPERATIONS, INC.

12.8.1 COMPANY SNAPSHOT

12.8.2 REVENUE ANALYSIS

12.8.3 PRODUCT PORTFOLIO

12.8.4 RECENT DEVELOPMENT

12.9 KARL STORZ

12.9.1 COMPANY SNAPSHOT

12.9.2 PRODUCT PORTFOLIO

12.9.3 RECENT DEVELOPMENT

12.1 STRYKER

12.10.1 COMPANY SNAPSHOT

12.10.2 REVENUE ANALYSIS

12.10.3 PRODUCT PORTFOLIO

12.10.4 RECENT DEVELOPMENT

13 QUESTIONNAIRE

14 RELATED REPORTS